Depression is one of the most common mental health conditions, and some people recover with medications or therapies. However ...

BPL-003 (mebufotenin benzoate nasal spray) granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for ...

Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...

A second dose of an investigational nasal spray formulation of mebufotenin benzoate -- a tryptamine psychedelic -- offered ...

TRICARE coverage is primarily used by active and retired military service members and their eligible family members. This policy update, effective immediately, applies to TRICARE beneficiaries in the ...

Under federal law, simple possession of psilocybin is punishable by up to a year in jail and a minimum fine of $1,000.

The ketogenic diet significantly improves symptoms in epilepsy, schizophrenia, as well as in alcohol use disorder, opioid use ...

If data is the oil of the 21st century, then “brain” data is the crude oil. We need to guard it more jealously. Right now, in most jurisdictions around the world, there is no law preventing tech ...

Speaking to Sky News, Chair, Medical Psychedelics Working Group for Drug Science Professor Joanna Neill says: "This is a hugely significant treatment for very hard to treat conditions, like treatment ...

Reports Q3 revenue $749,000, consensus $55,560. “This has been a transformational quarter, highlighted by the establishment of AtaiBeckley, which ...

Early seizure onset in DEPDC5-related epilepsy is linked to more severe disease, including drug resistance, intellectual disability, and brain lesions.